跳至主要内容
临床试验/CTRI/2024/09/073502
CTRI/2024/09/073502尚未招募3 期

Effect of Guduchiarka in Rheumatoid arthritis

Divya K1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2024年9月30日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
24
试验地点
1
主要终点
Tenderness

研究概览

简要总结

The aim of the study is to determine the effect of Guduchi arka in Rheumatoid arthritis. This will be an interventional study with pre, intermediate and post assessment conducted in the OPD of Poomulli Neelakantan Namboodiripad Memorial Ayurveda Medical College and Hospital, Cheruthuruthy. Twenty four participants will be selected on the basis of inclusion criteria will be evaluated clinically in detail using a pre-designed case proforma. 24 ml of Guduchi arkawith 750 mg of Sunti churnaand24 ml of boiled and cooled water is given twice daily after food for a period of 30 days. Evaluation will be done on 0th, 16th and 31st day and changes in parameters will be recorded. The primary outcome measures will be tenderness, swelling, morning stiffness and Visual Analogue Scale which will be assessed on 0th,16th and 31st day and secondary outcomes like Rheumatoid Factor, Erythrocyte Sedimentation Rate , Disease Activity Score  and Quality of Life will be assessed on 0th and 31st day. The results obtained will be statistically analysed .

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Participants fulfilling the diagnostic criteria Age between
  • 60 years Participants irrespective of gender Participants willing to give informed consent.

排除标准

  • Pregnant and Lactating women Known case of malignancy Known case of systemic illness Known case of Gouty arthritis, psoriatic arthritis and osteoarthritis Under medication for Rheumatoid arthritis Complication of Rheumatoid arthritis.

结局指标

主要结局

Tenderness

时间窗: Assessment on 0th day, 16th day and 31st day

Morning Stiffness

时间窗: Assessment on 0th day, 16th day and 31st day

Swelling

时间窗: Assessment on 0th day, 16th day and 31st day

Visual Analogue Scale

时间窗: Assessment on 0th day, 16th day and 31st day

次要结局

  • Rheumatoid Factor(Erythrocyte Sedimentation Rate)

研究者

发起方
Divya K
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Divya K

Poomulli Neelakantan Namboodiripad Memorial Ayurveda Medical College and Hospital

研究点 (1)

Loading locations...

相似试验